Connor, Clark & Lunn Investment Management (CC&L)’s Rigel Pharmaceuticals RIGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.78M | Sell |
148,183
-9,741
| -6% | -$182K | 0.01% | 761 |
|
|
2025
Q1 | $2.84M | Buy |
157,924
+18,796
| +14% | +$338K | 0.01% | 641 |
|
|
2024
Q4 | $2.34M | Buy |
139,128
+41,122
| +42% | +$692K | 0.01% | 679 |
|
|
2024
Q3 | $1.59M | Buy |
98,006
+22,443
| +30% | +$363K | 0.01% | 729 |
|
|
2024
Q2 | $621K | Buy |
75,563
+2,307
| +3% | +$19K | ﹤0.01% | 993 |
|
|
2024
Q1 | $1.08M | Buy |
73,256
+14,355
| +24% | +$212K | ﹤0.01% | 858 |
|
|
2023
Q4 | $854K | Sell |
58,901
-262
| -0.4% | -$3.8K | ﹤0.01% | 903 |
|
|
2023
Q3 | $639K | Sell |
59,163
-896
| -1% | -$9.68K | ﹤0.01% | 958 |
|
|
2023
Q2 | $775K | Buy |
60,059
+1,720
| +3% | +$22.2K | ﹤0.01% | 870 |
|
|
2023
Q1 | $770K | Buy |
58,339
+1,060
| +2% | +$14K | ﹤0.01% | 782 |
|
|
2022
Q4 | $859K | Buy |
+57,279
| New | +$859K | ﹤0.01% | 743 |
|
|
2017
Q4 | – | Sell |
-1,014
| Closed | -$26K | – | 843 |
|
|
2017
Q3 | $26K | Sell |
1,014
-11,778
| -92% | -$302K | ﹤0.01% | 797 |
|
|
2017
Q2 | $349K | Sell |
12,792
-8,473
| -40% | -$231K | ﹤0.01% | 661 |
|
|
2017
Q1 | $704K | Sell |
21,265
-1,849
| -8% | -$61.2K | ﹤0.01% | 560 |
|
|
2016
Q4 | $550K | Sell |
23,114
-8,920
| -28% | -$212K | ﹤0.01% | 586 |
|
|
2016
Q3 | $1.18M | Sell |
32,034
-10,920
| -25% | -$401K | 0.01% | 450 |
|
|
2016
Q2 | $958K | Hold |
42,954
| – | – | 0.01% | 472 |
|
|
2016
Q1 | $893K | Sell |
42,954
-3,113
| -7% | -$64.7K | 0.01% | 475 |
|
|
2015
Q4 | $1.4M | Buy |
46,067
+5,822
| +14% | +$176K | 0.01% | 392 |
|
|
2015
Q3 | $994K | Buy |
40,245
+15,585
| +63% | +$385K | 0.01% | 402 |
|
|
2015
Q2 | $792K | Buy |
24,660
+10,120
| +70% | +$325K | 0.01% | 367 |
|
|
2015
Q1 | $519K | Buy |
14,540
+12,630
| +661% | +$451K | ﹤0.01% | 388 |
|
|
2014
Q4 | $43K | Buy |
+1,910
| New | +$43K | ﹤0.01% | 568 |
|
|
2014
Q2 | – | Sell |
-2,162
| Closed | -$93K | – | 617 |
|
|
2014
Q1 | $93K | Buy |
+2,162
| New | +$93K | ﹤0.01% | 653 |
|